Posts Tagged ‘Eugenics’

http://vactruth.com/2013/01/06/paralyzed-after-meningitis-vaccine/

http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN%2F4647773 Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Abstract A cell system is disclosed for the reproducible detection and isolation of human T-lymphotropic retroviruses (HTLV-family) with cytopathic effects (HTLV-III) from patients with the acquired immune deficiency syndrome (AIDS), pre-AIDS and in healthy carriers. One neoplastic aneuploid T-cell line derived from an adult with lymphoid leukemia, and termed HT, was susceptible to infection with the new variants of HTLV, which are transformed and providing T-cell populations which are highly susceptible and permissive from HTLV-III, and convenience for large scale production, isolation and biological detection of the virus. Inventors: Gallo; Robert C. (Bethesda, MD), Popovic; Mikulas (Bethesda, MD) Assignee: The United States of America as represented by the Department of Health (Washington, DC) [*] Notice: The portion of the term of this patent subsequent to May 28, 2002 has been disclaimed. Appl. No.: 06/602,946 Filed: April 23, 1984 Current U.S. Class: 435/239 ; 424/208.1; 435/235.1; 435/372.3; 435/948 Current International Class: C12N 5/06 (20060101); C12N 7/00 (20060101); C12N 007/02 (); C12N 007/00 (); C12N 005/00 (); C12R 001/91 () Field of Search: 435/235,239,240,948,5,29 424/89 128/1T References Cited [Referenced By] U.S. Patent Documents 4464465 August 1984 Lostrom et al. 4520113 May 1985 Gallo et al. Other References Popovic et al, Science, 224(4648):497-500, May 4, 1984. . Gallo et al, “Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)”, Science, 220, pp. 865-867 (5-1983). . Barre-Sinoussi et al, “Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for AIDS”, Science, 220, pp. 868-871 (5-1983). . Marx, “Strong New Candidate for AIDS Agent”, Science, 224, pp. 475-477 (5-1984).. Primary Examiner: Warren; Charles F. Assistant Examiner: Tarcza; John Edward Attorney, Agent or Firm: Roberts, Jr.; John S. Claims We claim: 1. A method for continuous production of HTLV-III virus which comprises infecting in cell culture highly susceptible, permissive cells consisting of a neoplastic aneuploid HT-cell line with said virus, said cells preserve the capacity for permanent growth after the infection with said virus, growing said cells under conditions suitable for cell growth and recovering said virus produced by said cells. 2. The method of claim 1, wherein said virus consists of cytopathic variants of HTLV. 3. The method of claim 1 wherein said infecting comprises cocultivating said virus with said cells to produce a cell line and recovering said cell line. 4. The method of claim 1 wherein said infecting comprises cell-free infection of said cells with said virus. 5. The method of claim 1 wherein said cells are neoplastic aneuploid T-cells derived from an adult with lymphoid leukemia. 6. A process for the continuous production of HTLV-III virus which comprises cocultivating said virus with a target HT-cell to produce an infected cell line, growing said cell line and recovering said virus from supernatants produced by said cell line. 7. The process of claim 6 wherein said target T-cell is a neoplastic aneuploid T-cell susceptible to infection with HTLV-III. 8. A process for the continual production of HTLV-III by infecting T-cells in cultures which comprises cocultivating HTLV-III virus with an HT-clone to produce an infected cell line, said clone being an aneuploid T-cell line derived from lymphoid leukemia, growing said cell line and recovering said virus from supernatants produced by said cell line. 9. The process in claim 8 wherein said clone is a mature T-cell phenotype of OKT3.sup.+ (62%), OKT4.sup.+ (39%) and OKT8.sup.-. 10. A method of producing a cell line containing an antigen of HTLV-III which comprises infecting an HT-cell line derived from lymphoid leukemia and susceptible to infection with HTLV-III, said cell line is capable of continuous large-scale production of HTLV-III, and growing the infected cell line under conditions suitable for growth. 11. The method of claim 10 wherein said cell line is a neoplastic aneuploid T-cell line. 12. The method of claim 10 wherein said HTLV-III are variants of human T-lymphotropic retrovirus, exhibit cytopathic effects and are non-transforming. 13. A cell line containing HTLV-III designated H9/HTLV-III.sub.B, ATCC Accession CRL 8543. 14. A process for producing a cell line H9/HTLV-III.sub.B which comprises infecting a target T-cell with HTLV-III virus to produce a cell line and recovering same, said infecting process overcomes the normal cytopathic effect of HTLV-III and preserves the immortal growth capacity of the target cell. 15. An HT cell line permanently infected with HTLV-III virus, wherein said cell line continually produces said virus. Description The present invention describes a cell system for the reproducible detection and isolation of human T-lymphotropic retroviruses (HTLV-family) with cytopathic or cell killing effects (HTLV-III) from patients with the acquired immune deficiency syndrome (AIDS), pre-AIDS and in healthy carriers. One neoplastic aneuploid T-cell line derived from an adult with lymphoid leukemia, and termed HT, was susceptible to infection with the new variants of HTLV, providing T-cell populations which are highly susceptible and permissive for HTLV-III, and convenience for large scale production, isolation, and biological detection of the virus. BACKGROUND OF THE INVENTION The disclosure of this invention is contained in the following journal articles: Gallo et al., “Detection, Isolation, and Continuous Production of Cytopathic Human T-Lymphotropic Retroviruses (HTLV-III) from Patients with AIDS and pre-AIDS,” Science, in press; and Gallo et al., “Human T-Lymphotropic Retrovirus, HTLV-III, Isolated from AIDS Patients and Donors at Risk for AIDS,” in press. Epidemiologic data strongly suggest that acquired immune deficiency syndrome (AIDS) is caused by an infectious agent which is apparently horizontally transmitted by intimate contact or blood products. Though the disease is manifested by opportunistic infections, predominantly Pneumocystis carcinii pneumonia and Kaposi’s sarcoma, the underlying disorder affects the patient’s cell-mediated immunity with absolute lymphopenia and reduced helper T-lymphocyte (OKT4.sup.+) subpopulation(s). Moreover, before a complete clinical manifestation of the disease occurs, its prodrome, pre-AIDS, is frequently characterized by unexplained chronical lymphadenopathy and/or leukopenia involving a helper T cell subset. This leads to the severe immune deficiency of the patient, suggesting that a specific subset of T-cells is the primary target for an infectious agent. Although patients with AIDS or pre-AIDS are often chronically infected with cytomegalovirus or hepatitis B virus, for various reasons these appear to be opportunistic or coincidental infections apparently not linked to the immunological response deficiency. It is believed that the cause of AIDS may be a virus from the family of human T-cell lymphotropic retroviruses (HTLV) which, prior to the present invention, comprised two major well characterized subgroups of human retroviruses, called human T-cell leukemia/lymphoma viruses, HTLV-I and HTLV-II. The most common isolate, HTLV-I, is mainly obtained from patients with mature T-cell malignancies. Seroepidemiological studies, in vitro biological effects, and nucleic acid hybridization data indicate that HTLV-I is etiologically associated with these malignancies, affecting adults primarily in the south of Japan, the Caribbean and Africa. HTLV of subgroup II (HTLV-II) was first isolated from a patient with a T-cell variant of hairy cell leukemia. To date, this is the only reported isolate of HTLV-II from a patient with a neoplastic disease. Virus isolation and seroepidemiological data show that HTLV of both subgroups can sometimes be found in patients with AIDS. Evidence suggests that the retrovirus(es) of the HTLV family is an etiological agent of AIDS based on the following: (1) there is precedence for an animal retrovirus cause of immune deficiency (feline leukemia virus in cats); (2) retroviruses of the HTLV family are T-cell tropic; (3) they preferentially infect “helper” T-cells (OKT4.sup.+); (4) they have cytopathic effects on various human and mammalian cells as demonstrated by their induction of cell syncytia formation; (5) they can alter some T-cell functions; (6) in some cases infection may result in selective T-cell killing; and (7) they are transmitted by intimate contact or through blood products. The presence of antibodies directed to cell membrane antigens of HTLV infected cells has been shown in sera of more than 40% of patients with AIDS [Essex et al., Science, 220:859 (1983)]. This antigen has since been defined as part of the envelope of HTLV [Schupbach, et al., Science, in press; and Lee, et al., Proc. Nat. Acad. Sci. U.S.A., in press]. The original detection and isolation of the various HTLV isolates were made possible by two earlier developments: the discovery of T-cell growth factor (TCGF), also called Interleukin 2 (Il-2), which enabled the routine selective growth of different subsets of normal and neoplastic mature T-cells [Ruscetti, et al., J. Immunol., 119:131 (1977); and Poiesz, et al., Proc. Nat. Acad. Sci. U.S.A, 77:6134 (1980)] and the development of sensitive assays for detection of retroviruses based on reverse transcriptase assays. The methods of HTLV isolation and transmission involved a cocultivation procedure using permissive T-cells for the virus. The use of normal human T-cells in cocultivation experiments preferentially yielded HTLV of both subgroups with immortalizing (transforming) capability for some of the target T-cells. However, HTLV variants (now termed HTLV-III), lack immortalizing properties for normal T-cells and mainly exhibit cytopathic effects on the T-cells and is now believed to be the cause of AIDS. In fact, such variants were frequently but only transiently detected using these normal T-cells as targets in cocultivation or cell-free transmission experiments. The cytopathic effect was overcome by finding a highly susceptible, permissive cell for cytopathic variants of HTLV, thus preserving the capacity for permanent growth after infection with the virus. The present invention discloses the identification and characterization of this new immortalized T-cell population and its use in the isolation and continuous high- level production of such viruses from patients with AIDS and pre-AIDS. Early experiments identified one neoplastic aneuploid T-cell line, termed HT, derived from an adult with lymphoid leukemia, that was susceptible to infection with the new cytopathic virus isolates. This cell line is a sensitive target for transmission of these virus isolates (HTLV-III) and it allows continuous large-scale virus production and development of specific immunologic reagents and nucleic acid probes useful for comparison of these new isolates among themselves and with HTLV-I and HTLV-II. In addition to their differences in biological effects that distinguish them from HTLV-I and HTLV-II, HTLV-III also differs from these known HTLV subgroups in several immunological assays and in morphology. However, these new retroviruses are T4 lymphotropic and exhibit many properties similar to HTLV-I and II, including similar properties of the reverse transcriptase, cross reactivity of structural proteins as determined by heterologous competition radioimmune assays with patients’ sera and with animal hyperimmune sera, and induction of syncytia. These new retrovirus isolates are collectively designated HTLV-III, together with detectable differences in some of their proteins and genetic information, HTLV-III’s ability to kill T-cells clearly separates these variants from other members of the HTLV family. Read the full patent via the US patent website

Australian Bill Allows for Sterilizations Without Parental Consent at Any Age

March 6, 2012

 

 

Anthony Gucciardi
BlacklistedNews.com

Following the call by ethicists for after-birth abortions and the press explosion surrounding the ‘Euthanasia Coaster‘, new legislation from Australia is now paving the way for children of any age to consent to sterilization — without parental consent. That’s right, if a psychiatrist determines that a child under the age of 18 years is ‘sufficiently mature’, they will be sterilized without any say from the parents. Again, there is no age minimum, as long as they are ‘mature‘ enough.

The legislation, known as the ‘Draft Mental Health Bill 2011′, also allows for 12-year-olds to consent to psychosurgery and electroshock. You can view the bill for yourselfon the Australian Mental Health government website. Written by the Western Australia Mental Health Commission (MHC) and overseen by Mental Health Commissioner and clinical psychologist Mr Eddie Bartnik, objections can still be submitted to Australian parliamentary members in each state until March 9th.

 

Some main points of the bill read:

  • CHILDREN OF ANY AGE TO CONSENT TO STERILISATION: If a psychiatrist decides that a child (under 18 years) has sufficient maturity, he or she will be able to consent to sterilisation. Parental consent will not be needed. Only after the sterilisation procedure has been performed does it have to be reported and then only to the Chief Psychiatrist. [Pages: 135 & 136 of the Draft Mental Health Bill 2011]
  • 12 YEAR OLDS WILL BE ABLE TO CONSENT TO PSYCHOSURGERY: Banned in N.S.W. and the N.T., psychosurgery irreversibly damages the brain by surgery, burning or inserting electrodes. This draft bill proposes to allow a 12 year old child, if considered to be sufficiently mature by a psychiatrist, to be able to consent to psychosurgery. Once the child has consented it goes before the Mental Health Tribunal (MHT) for approval. Parental consent is also not needed for the MHT to approve the psychosurgery. [Pages: 108, 109, 110, 197,198, 199, 213]
  • 12 YEAR OLDS WILL BE ABLE TO CONSENT TO ELECTROSHOCK (ECT): Electroshock is hundreds of volts of electricity to the head. Any child aged 12 and over, whom a child and adolescent psychiatrist decides is “mature” enough, will be able to consent to electroshock. Also, once consent is given, there is no requirement for parents or anyone, including the MHT, to approve the electroshock. Electroshock should be banned. Its use on the elderly, pregnant women and children is especially destructive. [Pages: 100, 101, 103, 104, 194, 105]
Action will need to be taken to make sure the bill does not pass. Objections can be sent to the Mental Health Commission and to Australian state legislators. Feedback options come to a close on the 9th of March at 5pm, so it is important to voice your opposition today. Here are a few ways to contact the Mental Health Commission and state your objection to the bill:
  • Mail: GPO Box X2299 Perth Business Centre, W.A. 6847

This article first appeared at Natural Society

FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of political, economic, scientific, and educational issues. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to:

http://www.law.cornell.edu/uscode/17/107.shtml.

If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

 

PN

RadChick
September 25, 2012

This is a breaking story…stay tuned as more details follow in the next few days. Please contact the reporter named in the video if you have info to share.

View original post

Truth11

Prisonplanet.com

Sept 29, 2012

The mainstream consciousness is becoming aware of the New World Order. Work by street artist MEAR ONE underscores the larger awakening underway, as his provocative murals strike strong public reaction.

View original post

The Extinction Protocol

September 26, 2012RUSSIARussian authorities temporary suspended the import and sale of Monsanto’s genetically-modified corn after a French study suggested it may be linked to cancer. ­The Russia’s consumer-rights regulator Rospotrebnadzor asked scientists at the country’s Institute of Nutrition to review the study. The watchdog has also contacted to European Commission’s Directorate General for Health & Consumers to explain the EU’s position on GM corn. The report prepared by France’s University of Caen and published last week, claimed that rats fed over a two-year period with Monsanto’s genetically modified NK603 corn, developed more tumors and other pathologies than a test group fed with regular corn. The NK603, sold under the Roundup label, is genetically engineered to withstand glyphosate weed killer. The company criticized the study, saying it “doesn’t meet minimum acceptable standards for this type of scientific research” and the data was incomplete. Monsanto also said Russia’s…

View original post 186 more words

Hidden Agendas

 

Uploaded by wrxstiable on Jul 27, 2009

This is true and its happening now. Please open your eyes people before we have no rights left to oppose. Save our next generation from being slaves. Global warming is a lie , It is part of agenda 21 of UN. UN will control the future world and soon humanity would be put on trial for ruining the earth and not preserving it for the generations to come. This is the mother of scams. Media is our enemy. All big names like cnn, fox, cnbc, bbc and many more have signed a contract with UN to keep their secrets and be their alloys in this so called “earth saving mission”.

Category:

People & Blogs

This video uses copyrighted material in a manner that does not require approval of the copyright holder. It is a fair use under copyright law.Copyright Disclaimer Under Section…

View original post 111 more words

Hidden Agendas

 

Published on May 31, 2012 by HOT4TECHNOLOGY

ChemTrail Seminar by Sofia Smallstorm

Category:

Education

This video uses copyrighted material in a manner that does not require approval of the copyright holder. It is a fair use under copyright law.Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for fair use for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.

View original post 14 more words

Hidden Agendas

 

Uploaded by exposethenwo2012 on Jan 17, 2009

We can trace the beginnings of Operation Cloverleaf right to the Strangelove brain of Dr. Edward Teller, father of the hydrogen bomb and proponent of nuking inhabited coast lines to rearrange them for economic projects. Before he died in 2003, Teller was director emeritus of Lawrence Livermore National Laboratory, where plans for nuclear, biological and directed energy weapons are crafted. In 1997, Teller publicly outlined his proposal to use aircraft to scatter in the stratosphere millions of tons of electrically-conductive metallic materials, ostensibly to reduce global warming.

View original post 47 more words

Truth11

Wednesday, August 29, 2012

Susanne Posel, Contributor
Activist Post

DeCODE Genetics (DCG) has published a study that states Icelandic fathers who are in their 40s pass down more genetic mutations than their 20 year-old counterparts. According the DCG, 97% of genetic mutations are derived from older fathers.

Because males produce sperm throughout their lives, and the genetic make-up of that sperm is created from mutations based on previously produced sperm. This study supposes that increase in autism could be connected to these genetic mutations.

This has led to an increase in genetic defects, suggests lead researcher Dr. Kari Stefansson. She asserts:

Society has been very focused on the age of the mother. But apart from [Down’s Syndrome] it seems that disorders such as schizophrenia and autism are influenced by the age of the father and not the mother.

Studies into DNA with regard to reproduction and children harken back…

View original post 757 more words